Advertisement
Screener

Humacyte, Inc. (HUMA) ROA

Humacyte, Inc. (HUMA) ROA

  • 2026-06-30: ROA -70.05%.
  • 2026-03-31: ROA -88.27%.
  • 2025-12-31: ROA -35.09%.
  • 2025-09-30: ROA -40.40%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-70.05%
2026-03-31-88.27%
2025-12-31-35.09%
2025-09-30-40.40%
2025-06-30-42.26%
2025-03-31-47.78%
2024-12-31-107.85%
2024-09-30-133.20%
2024-06-30-101.00%
2024-03-31-65.46%
2023-12-31-86.39%
2023-09-30-59.84%
2023-06-30-52.75%
2023-03-31-15.90%
2022-12-31-5.86%
2022-09-3015.18%
2022-06-3011.39%
2022-03-31-9.83%
2021-12-31-9.24%
2021-09-30-28.11%
2021-06-30-71.11%
2021-03-31-68.69%
2020-12-31-62.35%

Annual ROA

DateROA
2025-12-31-35.09%
2024-12-31-107.85%
2023-12-31-86.39%
2022-12-31-5.86%
2021-12-31-9.24%
2020-12-31-62.35%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63